Paper40149895
Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies.
Fatima M and 2 others. Biomolecules, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies. Papers, record 40149895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40149895
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| COVID-19 Vaccines | Major topic |
| RNA, Messenger | Major topic |
| Drug Delivery Systems | Major topic |
| mRNA Vaccines | Major topic |
| Vaccines, Synthetic | Major topic |
| Humans | |
| Nanoparticles | |
| SARS-CoV-2 | |
| Animals | |
| Lipids |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RS-2024-00331833 | Ministry of Food and Drug Safety | PubMed |
Source PubMed
References157
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36683074 | Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2. | Cell Discov | 2023 | https://conductscience.org/library/papers/36683074 | PubMed |
| 2 | 34145748 | mRNA Delivery by a pH-Responsive DNA Nano-Hydrogel. | Small | 2021 | https://conductscience.org/library/papers/34145748 | PubMed |
| 3 | 37363954 | Black Phosphorus Nanosheets Assist Nanoerythrosomes for Efficient mRNA Vaccine Delivery and Immune Activation. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37363954 | PubMed |
| 4 | 37195813 | Self-Assembly of Peptide-Lipid Nanoparticles for the Efficient Delivery of Nucleic Acids. | Langmuir | 2023 | https://conductscience.org/library/papers/37195813 | PubMed |
| 5 | 37111593 | Dendrimer-Mediated Delivery of DNA and RNA Vaccines. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111593 | PubMed |
| 6 | 32700581 | Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities. | Expert Opin Drug Deliv | 2020 | https://conductscience.org/library/papers/32700581 | PubMed |
| 7 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 8 | 20648001 | Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. | Mol Ther | 2010 | https://conductscience.org/library/papers/20648001 | PubMed |
| 9 | 26049133 | Nanoengineering of vaccines using natural polysaccharides. | Biotechnol Adv | 2015 | https://conductscience.org/library/papers/26049133 | PubMed |
| 10 | 26529392 | An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. | Nano Lett | 2015 | https://conductscience.org/library/papers/26529392 | PubMed |
| 11 | 35087403 | Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35087403 | PubMed |
| 12 | 38551046 | Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38551046 | PubMed |
| 13 | 36693871 | 3D RNA-scaffolded wireframe origami. | Nat Commun | 2023 | https://conductscience.org/library/papers/36693871 | PubMed |
| 14 | 39217793 | Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs. | Biomaterials | 2025 | https://conductscience.org/library/papers/39217793 | PubMed |
| 15 | 37779140 | Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37779140 | PubMed |
| 16 | 38820767 | mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo. | Biomaterials | 2024 | https://conductscience.org/library/papers/38820767 | PubMed |
| 17 | 38307296 | mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38307296 | PubMed |
| 18 | 35131941 | Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35131941 | PubMed |
| 19 | 37509124 | Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines. | Biomolecules | 2023 | https://conductscience.org/library/papers/37509124 | PubMed |
| 20 | 28832535 | Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. | Molecules | 2017 | https://conductscience.org/library/papers/28832535 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42963803 | Current strategies and challenges in vaccine platforms for Newcastle Disease Virus. | Trop Dis Travel Med Vaccines | 2026 | https://conductscience.org/library/papers/42963803 | PubMed |
| 42514871 | Analytical Characterization and Stability Assessment of RNA-Based Vaccines. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514871 | PubMed |
| 42473555 | Toward Safe and Effective Gene Therapy: Non-Viral Nanostructured Delivery Systems. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42473555 | PubMed |
| 42327479 | Efficacy and Safety of Messenger RNA Vaccines. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42327479 | PubMed |
| 42232345 | Bio-based nanomaterials in drug delivery: An updated review. | Pharm Sci Adv | 2026 | https://conductscience.org/library/papers/42232345 | PubMed |
| 41984335 | Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/41984335 | PubMed |
| 41657702 | Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov data. | Front Public Health | 2026 | https://conductscience.org/library/papers/41657702 | PubMed |
| 41385334 | mRNA vaccine platforms and novel delivery systems: From mechanistic principles to clinical translation. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/41385334 | PubMed |
| 41377933 | mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics. | Cancer Innov | 2025 | https://conductscience.org/library/papers/41377933 | PubMed |
| 41155704 | Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155704 | PubMed |
| 40430032 | Promising Vaccine Formulations for Emerging Infectious Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40430032 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40149895
GET https://conductscience.org/api/papers/v1/40149895/references?page=2